| For: | Brechmann T, Sperlbaum A, Schmiegel W. Levothyroxine therapy and impaired clearance are the strongest contributors to small intestinal bacterial overgrowth: Results of a retrospective cohort study. World J Gastroenterol 2017; 23(5): 842-852 [PMID: 28223728 DOI: 10.3748/wjg.v23.i5.842] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i5/842.htm |
| Number | Citing Articles |
| 1 |
Brittany Bohinc Henderson. Levothyroxine Sodium Oral Solution Normalizes Thyroid Function in a Patient with Hashimoto’s Disease, Gastritis, Diabetic Gastroparesis, and Small Intestinal Bacterial Overgrowth (SIBO). International Medical Case Reports Journal 2021; doi: 10.2147/IMCRJ.S326481
|
| 2 |
Adis Medical Writers. Use acid-suppressing drugs appropriately with an individualized approach to minimize the risk of infection. Drugs & Therapy Perspectives 2018; 34(2) doi: 10.1007/s40267-017-0473-z
|
| 3 |
A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2018; 40 doi: 10.1016/bs.seda.2018.08.011
|
| 4 |
A. A. Tulsky, O. A. Myrinova, A. O. Shchetinina, N. S. Martirosian, E. V. Goncharova, I. A. Kuzina, M. E. Telnova, F. V. Valeeva, N. A. Petunina. Association between gut microbiota and thyroid dysfunction. Meditsinskiy sovet = Medical Council 2024; (6) doi: 10.21518/ms2024-073.
|
| 5 |
Piotr Bargiel, Małgorzata Szczuko, Laura Stachowska, Piotr Prowans, Norbert Czapla, Marta Markowska, Jan Petriczko, Jakub Kledzik, Alicja Jędrzejczyk-Kledzik, Joanna Palma, Paulina Zabielska, Dominika Maciejewska-Markiewicz. Microbiome Metabolites and Thyroid Dysfunction. Journal of Clinical Medicine 2021; 10(16) doi: 10.3390/jcm10163609
|
| 6 |
M. Federici. Gut microbiome and microbial metabolites: a new system affecting metabolic disorders. Journal of Endocrinological Investigation 2019; 42(9) doi: 10.1007/s40618-019-01022-9
|
| 7 |
Chao Jia, Min Li, Xianqiang Yu. Gut microbiota and its metabolites with thyroid diseases: functions and mechanisms. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1818380
|
| 8 |
John A.H. Wass, Wiebke Arlt, Robert K. Semple, Birte Nygaard. Oxford Textbook of Endocrinology and Diabetes 3e. 2022; doi: 10.1093/med/9780198870197.003.0072
|
| 9 |
Brittany Bohinc Henderson, Shelby P. Smith, Marlena E. Mengelkamp, Emma Kate Rhymer, Kensi N. Gray, Abigail G. Jackson, Samantha F. Henry, Stacey Chuang, Erin H. Stavrakas, Olivia M. Blair, Melissa Heaps. Liquid Thyroxine Improves Outcomes in Hypothyroid Patients With Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome. Endocrine Practice 2024; 30(6) doi: 10.1016/j.eprac.2024.03.005
|
| 10 |
Natalia Sroka, Alicja Rydzewska-Rosołowska, Katarzyna Kakareko, Mariusz Rosołowski, Irena Głowińska, Tomasz Hryszko. Show Me What You Have Inside—The Complex Interplay between SIBO and Multiple Medical Conditions—A Systematic Review. Nutrients 2022; 15(1) doi: 10.3390/nu15010090
|
| 11 |
A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2019; 41 doi: 10.1016/bs.seda.2019.07.019
|
| 12 |
Trynke van der Boom, Eke G. Gruppen, Joop D. Lefrandt, Margery A. Connelly, Thera P. Links, Robin P.F Dullaart. Plasma branched chain amino acids are lower in short-term profound hypothyroidism and increase in response to thyroid hormone supplementation. Scandinavian Journal of Clinical and Laboratory Investigation 2020; 80(7) doi: 10.1080/00365513.2020.1804610
|
| 13 |
Leon Fisher, Alexander Fisher. Acid-Suppressive Therapy and Risk of Infections: Pros and Cons. Clinical Drug Investigation 2017; 37(7) doi: 10.1007/s40261-017-0519-y
|
| 14 |
Begoña Ruiz-Núñez, Rabab Tarasse, Emar F. Vogelaar, D. A. Janneke Dijck-Brouwer, Frits A. J. Muskiet. Higher Prevalence of “Low T3 Syndrome” in Patients With Chronic Fatigue Syndrome: A Case–Control Study. Frontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00097
|
| 15 |
Gillian M. Barlow, Mark Pimentel. Modern concepts of small intestinal bacterial overgrowth. Current Opinion in Gastroenterology 2025; 41(6) doi: 10.1097/MOG.0000000000001135
|
| 16 |
Sarah Talamantes, Faye Steiner, Sean Spencer, Leila Neshatian, Irene Sonu. Intestinal Methanogen Overgrowth (IMO) Is Associated with Delayed Small Bowel and Colonic Transit Time (TT) on the Wireless Motility Capsule (WMC). Digestive Diseases and Sciences 2024; 69(9) doi: 10.1007/s10620-024-08563-x
|
| 17 |
Margaret Wei, Sepideh Mehravar, Gabriela Leite, Parnian Naji, Gillian M Barlow, Ava Hosseini, Mohamad Rashid, Maritza Sanchez, Cristina M Fajardo, Mark Pimentel, Ruchi Mathur. Relationship Between Hypothyroidism, Risk of Small Intestinal Bacterial Overgrowth, and Duodenal Microbiome Alterations. The Journal of Clinical Endocrinology & Metabolism 2026; 111(3) doi: 10.1210/clinem/dgaf495
|
| 18 |
María José Mendoza-León, Ashutosh K. Mangalam, Alejandro Regaldiz, Enrique González-Madrid, Ma. Andreina Rangel-Ramírez, Oscar Álvarez-Mardonez, Omar P. Vallejos, Constanza Méndez, Susan M. Bueno, Felipe Melo-González, Yorley Duarte, Ma. Cecilia Opazo, Alexis M. Kalergis, Claudia A. Riedel. Gut microbiota short-chain fatty acids and their impact on the host thyroid function and diseases. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1192216
|
| 19 |
Luciano Kowalski Coelho, Nayara Salgado Carvalho, Tomas Navarro-Rodriguez, Fernando Augusto Lima Marson, Paulo Jose Pereira Campos Carvalho. Lactulose Breath Testing Can Be a Positive Predictor Before Weight Gain in Participants with Obesity Submitted to Roux-en-Y Gastric Bypass. Obesity Surgery 2019; 29(11) doi: 10.1007/s11695-019-04006-z
|
| 20 |
Sophie Marin, Ching Jian, Alejandro Ávila-Aguirre, Henriette Raventós, Anne Salonen. Description of the fecal microbiota of siblings from Costa Rica with and without affective and psychotic disorders. Journal of Affective Disorders Reports 2021; 4 doi: 10.1016/j.jadr.2021.100081
|
| 21 |
Bartosz Bogielski, Katarzyna Michalczyk, Piotr Głodek, Bartosz Tempka, Wojciech Gębski, Dominika Stygar. Association between small intestine bacterial overgrowth and psychiatric disorders. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1438066
|
| 22 |
Paulina Roszkowska, Emilia Klimczak, Ewa Ostrycharz, Aleksandra Rączka, Iwona Wojciechowska-Koszko, Andrzej Dybus, Yeong-Hsiang Cheng, Yu-Hsiang Yu, Szymon Mazgaj, Beata Hukowska-Szematowicz. Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases—Current State of Knowledge. Biomedicines 2024; 12(5) doi: 10.3390/biomedicines12051030
|
| 23 |
Ana Maria Koller, Maria Oana Săsăran, Ancuța Lupu, Cristina Oana Mărginean. Antibiotic therapy for small intestinal bacterial overgrowth: a systematic review of comparative efficacy, clinical–test discordance, and pediatric evidence gaps. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1908516
|
| 24 |
Camilla Virili, Ilaria Stramazzo, Marco Centanni. Gut microbiome and thyroid autoimmunity. Best Practice & Research Clinical Endocrinology & Metabolism 2021; 35(3) doi: 10.1016/j.beem.2021.101506
|
| 25 |
Eamonn M. M. Quigley. The Spectrum of Small Intestinal Bacterial Overgrowth (SIBO). Current Gastroenterology Reports 2019; 21(1) doi: 10.1007/s11894-019-0671-z
|
| 26 |
Michael Ruscio, Gavin Guard, Gabriela Piedrahita, Christopher R. D’Adamo. The Relationship between Gastrointestinal Health, Micronutrient Concentrations, and Autoimmunity: A Focus on the Thyroid. Nutrients 2022; 14(17) doi: 10.3390/nu14173572
|
| 27 |
Amirreza Rafiei Javazm. Hypothyroidism - Causes, Screening and Therapeutic Approaches. 2024; doi: 10.5772/intechopen.1005506
|
| 28 |
A. S. Teplova, T. Y. Demidova, K. G. Lobanova. The relationship of endocrine and gastroenterological pathology: dietary fiber as a mechanism of management. FOCUS. Endocrinology 2023; 4(3) doi: 10.15829/2713-0177-2023-3-15
|